Small molecule ago-allosteric modulators of the human glucagon-like peptide-1 (hGLP-1) receptor

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 19, 2007, Pages 5472-5478

  Teng, Min ^a   Johnson, Michael D ^a   Thomas, Christine ^a   Kiel, Dan ^a   Lakis, James N ^a   Kercher, Tim ^a   Aytes, Shelley ^a   Kostrowicki, Jarek ^a   Bhumralkar, Dilip ^a   Truesdale, Larry ^a   May, John ^a   Sidelman, Ulla ^b   Kodra, Janos T ^b   Jørgensen, Anker Steen ^b   Olesen, Preben Houlberg ^b   de Jong, Johannes Cornelis ^b   Madsen, Peter ^b   Behrens, Carsten ^b   Pettersson, Ingrid ^b   Knudsen, Lotte Bjerre ^b   Holst, Jens J ^c   Lau, Jesper ^b   more..

^a PFIZER INC   (United States)

^b NOVO NORDISK A S   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

GLP 1; Quinoxaline

Indexed keywords

ALKYL GROUP; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; QUINOXALINE DERIVATIVE;

ALLOSTERISM; ARTICLE; HUMAN; HUMAN CELL; MOLECULE; STRUCTURE ACTIVITY RELATION;

ANTIGENS, CD26; CYCLIC AMP; HUMANS; INDICATORS AND REAGENTS; MOLECULAR CONFORMATION; PROTEASE INHIBITORS; RECEPTORS, GLUCAGON; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34548548357     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.06.086     Document Type: Article

References (20)

1. Kreymann B., Ghatai M.A., Williams G., and Bloom S.R. Lancet 2 (1987) 1300
2. Kieffer T.J., and Habener J.F. Endocr. Rev. 20 (1999) 876
3. Drucker D., Phillippe J., Mosjov S., Chick W., and Habener J. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 3434
4. Wheeler M.B., Lu M., Dillon J.S., et al. Endocrinology 133 (1993) 57
5. Lu M., Wheeler M.B., Leng X.H., and Boyed A.E.D. Endocrinology 132 (1993) 94
6. Yada T., Itoh K., and Nakata M. Endocrinology 133 (1993) 1685
7. Holz C.G.T., Kuhtreiber W.M., and Habener J.F. Nature 361 (1993) 362
8. Nauck M.A., Kleine N., Orskow C., Holst J.J., Willms B., and Creutzfeldt W. Diabetologia 36 (1993) 741
9. Zander M., Madsbad S., Madsen J.L., and Holst J.J. Lancet 359 (2002) 824
10. Vahl T.P., and D'Alessio D.A. Exp. Opin. Invest. Drugs 13 (2004) 177
11. Murphy K.G., and Bloom S.R. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 689
12. Nauck M.A., Wollschlager D., Werner J., Holst J.J., Orskov C., Creutzfeldt W., et al. Diabetologia 39 (1996) 1546
13. Juhl C.B., Hollingdal M., Sturis J., Jakobsen G., Agerso H., Veldhuis J., et al. Diabetes 51 (2002) 424
14. Elbrønd B., Jakobsen G., Larsen S., Agersø H., Jensen L.B., Rolam P., Sturis J., Hatorp V., and Zdravkovic M. Diabetes Care 25 (2002) 1398
15. Kolterman O.G., Buse J.B., Fineman M.S., Gaines E., Heintz S., Bicsak T.A., et al. J. Clin. Endocrinol. Metab. 88 (2003) 3082
16. Chen D., Liao J., et al. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 943
17. Knudsen L.B., Kiel D., Teng M., et al. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 937
18. Iddon B., Kutschy P., Robinson A.G., Suschitzky H., Kramer W., and Neugebauer F.A. J. Chem. Soc., Perkin Trans. 1: Org. Bioorg. Chem. 22 (1992) 3129
19. Cordi A.A., Desos P., Randle J.C.R., and Lepagnol J. Bioorg. Med. Chem. 3 (1995) 129
20. Desos P., Lepagnol J., Morain P., Lestage P., and Cordi A.A. J. Med. Chem. 39 (1996) 197